[Federal Register Volume 64, Number 33 (Friday, February 19, 1999)]
[Notices]
[Page 8388]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-4113]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Vaccines and Related Biological Products Advisory Committee; 
Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Vaccines and Related Biological Products 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on March 11, 1999, 12:30 
p.m. to 3:30 p.m.
    Location: Food and Drug Administration, Bldg. 29, conference room 
121, 8800 Rockville Pike, Bethesda, MD. This meeting will be held by 
telephone conference call. A speaker telephone will be provided in the 
conference room to allow public participation in the meeting.
    Contact Person: Nancy T. Cherry or Denise H. Royster, Center for 
Biologics Evaluation and Research (HFM-71), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, or FDA 
Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
the Washington, DC area), code 12391. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: This committee will complete recommendations pertaining to 
the influenza virus vaccine formulation for the 1999 to 2000 influenza 
season.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by March 4, 1999. 
Oral presentations from the public will be scheduled between 
approximately 1:45 p.m. and 2:45 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before March 4, 1999, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 11, 1999.
 Michael A. Friedman,
 Deputy Commissioner for Operations.
[FR Doc. 99-4113 Filed 2-18-99; 8:45 am]
BILLING CODE 4160-01-F